(ASGN) ASGN - Overview
Sector: Technology | Industry: Information Technology Services | Exchange: NYSE (USA) | Market Cap: 834m USD | Total Return: -64.7% in 12m
Avg Turnover: 26.8M
EPS Trend: -99.5%
Qual. Beats: -1
Rev. Trend: -96.6%
Qual. Beats: 0
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
ASGN Incorporated is a provider of IT services and professional solutions operating through two primary segments: Commercial and Federal Government. The company serves Fortune 1000 firms and government agencies, offering specialized expertise in cloud infrastructure, cybersecurity, artificial intelligence, and software engineering. Its business model relies on a mix of high-end consulting and technical talent placement, utilizing established brands such as Apex Systems and ECS to deliver mission-critical digital transformation projects.
The company operates within the Human Resource and Employment Services sub-industry, a sector that is increasingly shifting from traditional staffing toward high-margin technical consulting. This transition allows firms like ASGN to capture greater value from the growing demand for specialized digital skills across the defense, healthcare, and financial services sectors. Investors may find it useful to review ValueRay for deeper insights into the companys valuation metrics.
Founded in 1985 and headquartered in Glen Allen, Virginia, ASGN has evolved from a specialized staffing firm into a comprehensive IT services provider. The Federal Government segment specifically targets defense and intelligence clients, providing a stable revenue stream through long-term public sector contracts that often require high-level security clearances.
- Commercial segment demand softens as enterprise IT spending slows
- Federal segment growth accelerates via defense and intelligence contracts
- EBITDA margins compress due to lower permanent placement volume
- Strategic acquisitions in AI and cloud expand high-margin consulting revenue
| Net Income: 98.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -0.84 > 1.0 |
| NWC/Revenue: 12.36% < 20% (prev 12.64%; Δ -0.28% < -1%) |
| CFO/TA 0.09 > 3% & CFO 329.6m > Net Income 98.1m |
| Net Debt (1.37b) to EBITDA (446.3m): 3.06 < 3 |
| Current Ratio: 2.16 > 1.5 & < 3 |
| Outstanding Shares: last quarter (41.4m) vs 12m ago -5.91% < -2% |
| Gross Margin: 27.72% > 18% (prev 0.29%; Δ 2.74k% > 0.5%) |
| Asset Turnover: 107.9% > 50% (prev 108.7%; Δ -0.74% > 0%) |
| Interest Coverage Ratio: 1.91 > 6 (EBITDA TTM 446.3m / Interest Expense TTM 170.4m) |
| A: 0.13 (Total Current Assets 916.2m - Total Current Liabilities 424.3m) / Total Assets 3.68b |
| B: 0.30 (Retained Earnings 1.09b / Total Assets 3.68b) |
| C: 0.09 (EBIT TTM 325.2m / Avg Total Assets 3.69b) |
| D: 0.58 (Book Value of Equity 1.09b / Total Liabilities 1.87b) |
| Altman-Z'' = 3.05 = A |
| DSRI: 0.90 (Receivables 674.4m/755.1m, Revenue 3.98b/4.02b) |
| GMI: 1.03 (GM 27.72% / 28.56%) |
| AQI: 1.00 (AQ_t 0.73 / AQ_t-1 0.72) |
| SGI: 0.99 (Revenue 3.98b / 4.02b) |
| TATA: -0.06 (NI 98.1m - CFO 329.6m) / TA 3.68b) |
| Beneish M = -3.15 (Cap -4..+1) = AA |
As of May 25, 2026, the stock is trading at USD 19.50 with a total of 1,096,293 shares traded.
Over the past week, the price has changed by +8.57%,
over one month by +2.79%,
over three months by -51.85% and
over the past year by -64.73%.
ASGN has received a consensus analysts rating of 3.38. Therefore, it is recommended to hold ASGN.
- StrongBuy: 2
- Buy: 1
- Hold: 4
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 33.3 | 70.9% |
P/E Trailing = 8.68
P/E Forward = 7.4906
P/S = 0.2095
P/B = 0.4656
P/EG = 0.6389
Revenue TTM = 3.98b USD
EBIT TTM = 325.2m USD
EBITDA TTM = 446.3m USD
Long Term Debt = 1.46b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 1.53b USD (corrected: LT Debt 1.46b + ST Debt none) + Leases 64.4m
Net Debt = 1.37b USD (calculated: Debt 1.53b - CCE 161.2m)
Enterprise Value = 2.20b USD (833.9m + Debt 1.53b - CCE 161.2m)
Interest Coverage Ratio = 1.91 (Ebit TTM 325.2m / Interest Expense TTM 170.4m)
EV/FCF = 7.33x (Enterprise Value 2.20b / FCF TTM 300.0m)
FCF Yield = 13.64% (FCF TTM 300.0m / Enterprise Value 2.20b)
FCF Margin = 7.54% (FCF TTM 300.0m / Revenue TTM 3.98b)
Net Margin = 2.46% (Net Income TTM 98.1m / Revenue TTM 3.98b)
Gross Margin = 27.72% ((Revenue TTM 3.98b - Cost of Revenue TTM 2.88b) / Revenue TTM)
Gross Margin QoQ = 25.77% (prev 26.89%)
Tobins Q-Ratio = 0.60 (Enterprise Value 2.20b / Total Assets 3.68b)
Interest Expense / Debt = 11.16% (Interest Expense 170.4m / Debt 1.53b)
Taxrate = 48.11% (5.10m / 10.6m)
NOPAT = 168.7m (EBIT 325.2m * (1 - 48.11%))
Current Ratio = 2.16 (Total Current Assets 916.2m / Total Current Liabilities 424.3m)
Debt / Equity = 0.85 (Debt 1.53b / totalStockholderEquity, last quarter 1.80b)
Debt / EBITDA = 3.06 (Net Debt 1.37b / EBITDA 446.3m)
Debt / FCF = 4.55 (Net Debt 1.37b / FCF TTM 300.0m)
Total Stockholder Equity = 1.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.66% (Net Income 98.1m / Total Assets 3.68b)
RoE = 5.40% (Net Income TTM 98.1m / Total Stockholder Equity 1.82b)
RoCE = 9.92% (EBIT 325.2m / Capital Employed (Equity 1.82b + L.T.Debt 1.46b))
RoIC = 5.21% (NOPAT 168.7m / Invested Capital 3.24b)
WACC = 6.53% (E(833.9m)/V(2.36b) * Re(7.89%) + D(1.53b)/V(2.36b) * Rd(11.16%) * (1-Tc(0.48)))
Discount Rate = 7.89% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.88 | Cagr: -5.93%
[DCF] Terminal Value 73.98% ; FCFF base≈313.1m ; Y1≈288.4m ; Y5≈257.0m
[DCF] Fair Price = 65.61 (EV 4.08b - Net Debt 1.37b = Equity 2.71b / Shares 41.3m; r=8.35% [WACC [floored]]; 5y FCF grow -9.86% → 2.50% )
EPS Correlation: -99.52 | EPS CAGR: -13.17% | SUE: -4.0 | # QB: -1
Revenue Correlation: -96.64 | Revenue CAGR: -5.69% | SUE: -0.33 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.82 | Chg30d=-35.79% | Revisions=+33% | Analysts=7
EPS next Quarter (2026-09-30): EPS=1.07 | Chg30d=-23.11% | Revisions=-20% | Analysts=7
EPS current Year (2026-12-31): EPS=3.62 | Chg30d=-27.78% | Revisions=-20% | GrowthEPS=-20.5% | GrowthRev=-1.0%
EPS next Year (2027-12-31): EPS=4.56 | Chg30d=-20.96% | Revisions=-20% | GrowthEPS=+26.1% | GrowthRev=+2.9%
[Analyst] Revisions Ratio: +33%